63 related articles for article (PubMed ID: 21862667)
21. Characteristics of Circulating Immune Complexes in HIV-Infected Patients with Different Viral Load.
Korolevskaya LB; Shmagel KV; Shmagel NG
Bull Exp Biol Med; 2015 Aug; 159(4):469-71. PubMed ID: 26388572
[TBL] [Abstract][Full Text] [Related]
22. Characterization and structural analysis of HIV-1 integrase conservation.
Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
[TBL] [Abstract][Full Text] [Related]
23. The absence of anti-Tat antibodies is associated with risk of disease progression in HIV-2 infection.
Rodriguez SK; Sarr AD; Olorunnipa O; Popper SJ; Gueye-Ndiaye A; Traoré I; Dia MC; Mboup S; Kanki PJ
J Infect Dis; 2006 Sep; 194(6):760-3. PubMed ID: 16941341
[TBL] [Abstract][Full Text] [Related]
24. Temporal development and prognostic value of antibody response to the major neutralizing epitopes of gp120 during HIV-1 infection.
Turbica I; Simon F; Besnier JM; LeJeune B; Choutet P; Goudeau A; Barin F
J Med Virol; 1997 Jul; 52(3):309-15. PubMed ID: 9210041
[TBL] [Abstract][Full Text] [Related]
25. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.
Martinez V; Diemert MC; Braibant M; Potard V; Charuel JL; Barin F; Costagliola D; Caumes E; Clauvel JP; Autran B; Musset L;
Clin Infect Dis; 2009 Jan; 48(1):123-32. PubMed ID: 19035778
[TBL] [Abstract][Full Text] [Related]
26. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
Gupta S; Singh S
BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948
[TBL] [Abstract][Full Text] [Related]
27. HIV antibody responses in children of HIV-infected mothers.
Sever JL; Rakusan TA; Campos JM; O'Donnell RM; Price VA
Pediatr AIDS HIV Infect; 1996 Aug; 7(4):246-53. PubMed ID: 11361717
[TBL] [Abstract][Full Text] [Related]
28. Antibodies against RNA hydrolyze RNA and DNA.
Krasnorutskii MA; Buneva VN; Nevinsky GA
J Mol Recognit; 2008; 21(5):338-47. PubMed ID: 18729241
[TBL] [Abstract][Full Text] [Related]
29. Immunodominant epitope regions of HIV-1 reverse transcriptase: correlations with HIV-1+ serum IgG inhibitory to polymerase activity and with disease progression.
Grimison B; Laurence J
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 May; 9(1):58-68. PubMed ID: 7536108
[TBL] [Abstract][Full Text] [Related]
30. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
[TBL] [Abstract][Full Text] [Related]
31. Identification by phage display selection of a short peptide able to inhibit only the strand transfer reaction catalyzed by human immunodeficiency virus type 1 integrase.
Desjobert C; de Soultrait VR; Faure A; Parissi V; Litvak S; Tarrago-Litvak L; Fournier M
Biochemistry; 2004 Oct; 43(41):13097-105. PubMed ID: 15476403
[TBL] [Abstract][Full Text] [Related]
32. The use of a new in vitro reaction substrate reproducing both U3 and U5 regions of the HIV-1 3'-ends increases the correlation between the in vitro and in vivo effects of the HIV-1 integrase inhibitors.
Tramontano E; Onidi L; Esposito F; Badas R; La Colla P
Biochem Pharmacol; 2004 May; 67(9):1751-61. PubMed ID: 15081874
[TBL] [Abstract][Full Text] [Related]
33. Mapping epitopes of monoclonal antibodies against HIV-1 integrase with limited proteolysis and matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
Yi J; Skalka AM
Biopolymers; 2000; 55(4):308-18. PubMed ID: 11169922
[TBL] [Abstract][Full Text] [Related]
34. Impact of highly active antiretroviral therapy on the maturation of anti-HIV-1 antibodies during primary HIV-1 infection.
Adalid-Peralta L; Grangeot-Keros L; Rudent A; Ngo-Giang-Huong N; Krzysiek R; Goujard C; Deveau C; Le Gall M; Meyer L; Emilie D; Rouzioux C
HIV Med; 2006 Nov; 7(8):514-9. PubMed ID: 17105510
[TBL] [Abstract][Full Text] [Related]
35. Peptides that bind the HIV-1 integrase and modulate its enzymatic activity--kinetic studies and mode of action.
Levin A; Benyamini H; Hayouka Z; Friedler A; Loyter A
FEBS J; 2011 Jan; 278(2):316-30. PubMed ID: 21156026
[TBL] [Abstract][Full Text] [Related]
36. Viral studies of mothers with human immunodeficiency virus infection at delivery and their infants in the first 3 days of life.
Sison AV; Brandt CD; Rakusan TA; Wientzen R; Fuccillo DA; Sever JL
Pediatr AIDS HIV Infect; 1996 Oct; 7(5):325-30. PubMed ID: 11361490
[TBL] [Abstract][Full Text] [Related]
37. Amniotic fluid has higher relative levels of lentivirus-specific antibodies than plasma and can contain neutralizing antibodies.
Jaspan HB; Robinson JE; Amedee AM; Van Dyke RB; Garry RF
J Clin Virol; 2004 Nov; 31(3):190-7. PubMed ID: 15465411
[TBL] [Abstract][Full Text] [Related]
38. Autoantibodies in HIV-infected patients: Cross site-specific hydrolysis of H1 histone and myelin basic protein.
Baranova SV; Dmitrienok PS; Buneva VN; Nevinsky GA
Biofactors; 2019 Mar; 45(2):211-222. PubMed ID: 30496641
[TBL] [Abstract][Full Text] [Related]
39. HIV-Infected Patients: Cross Site-Specific Hydrolysis of H3 and H4 Histones and Myelin Basic Protein with Antibodies against These Three Proteins.
Baranova SV; Dmitrenok PS; Buneva VN; Sedykh SE; Nevinsky GA
Molecules; 2021 Jan; 26(2):. PubMed ID: 33435385
[TBL] [Abstract][Full Text] [Related]
40. Catalase Activity of IgG and κκ-IgG, λλ-IgG, and κλ-IgG Subfractions in HIV-Infected Patients and Healthy Donors.
Tolmacheva AS; Sedykh SE; Onvumere MK; Timofeeva AM; Maksimenko LV; Gashnikova NM; Nevinsky GA
Front Biosci (Landmark Ed); 2024 May; 29(5):191. PubMed ID: 38812328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
